Patients, Healthcare Providers, and Office Staff May Find the Following Resources Useful When Navigating the MONJUVI® (tafasitamab‑cxix) Patient Journey
Learn more about MONJUVI treatment and what to expect when getting started with MONJUVI.
MONJUVI Patient Brochure (2.5 MB)
Reimbursement, Appeals, and Billing and Coding for MONJUVI
Effective April 1, 2021, MONJUVI has been assigned J9349: Injection, tafasitamab-cxix, 2mg. Access these resources and references to help assist with the reimbursement process for MONJUVI.
J-Code Quick Reference Guide (2 MB)
- Product Codes
- Procedure Codes
- National Drug Codes (NDCs)
- Revenue Codes for the physician office setting as well as the hospital outpatient setting
Sample Claim Forms:
Sample Appeals Letters:
Sample Appeal Letter (63 KB)
MONJUVI Product Ordering Guide (623 KB)